These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11953338)

  • 1. Clinical and economic consequences of dyspepsia in the community.
    Moayyedi P; Mason J
    Gut; 2002 May; 50 Suppl 4(Suppl 4):iv10-2. PubMed ID: 11953338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
    BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zero inflated statistical count models for analysing the costs imposed by GERD and dyspepsia.
    Akbarzadeh Baghban A; Pourhoseingholi A; Zayeri F; Ashtari S; Zali MR
    Arab J Gastroenterol; 2013 Dec; 14(4):165-8. PubMed ID: 24433646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care.
    Duggan AE; Elliott CA; Miller P; Hawkey CJ; Logan RF
    Aliment Pharmacol Ther; 2009 Jan; 29(1):55-68. PubMed ID: 18801056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of gastro-oesophageal reflux disease and dyspepsia: A community-based study.
    Moghimi-Dehkordi B; Vahedi M; Khoshkrood Mansoori B; Kasaeian A; Safaee A; Habibi M; Pourhoseingholi A; Pourhoseingholi MA; Zali MR
    Arab J Gastroenterol; 2011 Jun; 12(2):86-9. PubMed ID: 21684479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
    McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
    Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
    Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
    BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran.
    Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
    Dig Liver Dis; 2008 Jun; 40(6):412-7. PubMed ID: 18342588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of cardiovascular diseases in the United Kingdom.
    Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
    Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of treated benign prostatic hyperplasia in the United Kingdom.
    Drummond MF; McGuire AJ; Black NA; Petticrew M; McPherson CK
    Br J Urol; 1993 Mar; 71(3):290-6. PubMed ID: 7682886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
    Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
    Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dyspepsia and heartburn in primary care: a rational and economic approach].
    Labenz J
    MMW Fortschr Med; 2009 Aug; 151(34-35):47-8. PubMed ID: 19771792
    [No Abstract]   [Full Text] [Related]  

  • 13. The economic impact of sight loss and blindness in the UK adult population.
    Pezzullo L; Streatfeild J; Simkiss P; Shickle D
    BMC Health Serv Res; 2018 Jan; 18(1):63. PubMed ID: 29382329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional dyspepsia: the economic impact to patients.
    Lacy BE; Weiser KT; Kennedy AT; Crowell MD; Talley NJ
    Aliment Pharmacol Ther; 2013 Jul; 38(2):170-7. PubMed ID: 23725230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of dyspepsia across the primary-secondary healthcare interface.
    Hungin AP; Rubin GP
    Dig Dis; 2001; 19(3):219-24. PubMed ID: 11752840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β
    Pavord ID; Mathieson N; Scowcroft A; Pedersini R; Isherwood G; Price D
    NPJ Prim Care Respir Med; 2017 Mar; 27(1):17. PubMed ID: 28270657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: East-West differences in the economic impact of functional dyspepsia.
    Mahadeva S; Goh KL
    Aliment Pharmacol Ther; 2013 Sep; 38(6):655. PubMed ID: 23964735
    [No Abstract]   [Full Text] [Related]  

  • 19. A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial.
    Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
    Gastroenterology; 2005 Dec; 129(6):1910-7. PubMed ID: 16344059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: East-West differences in the economic impact of functional dyspepsia--authors' reply.
    Lacy BE; Crowell MD; Talley NJ
    Aliment Pharmacol Ther; 2013 Sep; 38(6):656. PubMed ID: 23964736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.